Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;43(1):649-656.
doi: 10.1080/08897077.2021.1986878. Epub 2021 Nov 30.

Opioid use during pregnancy: An analysis of comment data from the 2016 Pregnancy Risk Assessment Monitoring System survey

Megan O'Connor  1 , Michaila Czarnik  1 , Brian Morrow  1 , Denise D'Angelo  1
Affiliations

Opioid use during pregnancy: An analysis of comment data from the 2016 Pregnancy Risk Assessment Monitoring System survey

Megan O'Connor et al. Subst Abus. 2022.

Abstract

ABTSTRACTBackground: Opioid misuse during pregnancy has been associated with adverse infant outcomes including preterm birth, stillbirth, and neonatal opioid withdrawal syndrome. The Pregnancy Risk Assessment Monitoring System (PRAMS) is an on-going state-based surveillance system of maternal behaviors, attitudes, and experiences prior to, during, and after pregnancy. Methods: We analyzed qualitative comments related to opioid use during pregnancy collected in 2016 from an open-ended prompt at the end of the PRAMS survey in 35 states (N = 40,408). Key word searches were conducted on the open-ended responses (n = 9,549) to identify opioid-related content with an automated function using Microsoft Excel. All responses from the initial screening (n = 1,035) were manually reviewed, and 69 responses were confirmed to relate to the respondent's personal experience with opioid use during pregnancy. Content analysis was conducted by 3 independent coders; key themes were compiled, discussed, and finalized by the coding team. Results: Five key themes related to opioid use during pregnancy were identified: (1) gratitude for treatment, recovery, and healthy infants; (2) pregnancy as motivation to seek treatment; (3) difficulty finding prenatal care providers with training in substance use disorders; (4) concern about the effects of treatment on the infant; and (5) experiences of discrimination and stigma in the hospital around the time of delivery. Conclusions: Women may be aware of the potential impact of opioid use during pregnancy on the health of their infants and motivated to seek treatment. Findings may help inform new and ongoing initiatives designed to improve care and reduce stigma for women needing or seeking treatment.

Keywords: PRAMS; opioids; pregnancy; qualitative data; stigma.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
PRAMS sites collecting data, PRAMS 2016.
Figure 2.
Figure 2.
List of common words and misspellings included in keyword search to identify opioid related open-ended comments from the Pregnancy Risk Assessment Monitoring System in 2016.
Figure 3.
Figure 3.
Selection of PRAMS records for inclusion in qualitative analysis of experiences with opioid use around the time of pregnancy.
See this image and copyright information in PMC

References

    1. U.S. Department of Health & Human Services. HHS Acting Secretary Declares Public Health Emergency to Address National Opioid Crisis. 2017. https://www.hhs.gov/about/news/2017/10/26/hhs-acting-secretary-declares-.... Published October 26, 2017. Accessed August 8, 2019.
    1. Leech AA, Cooper WO, McNeer E, Scott TA, Patrick SW. Neonatal abstinence syndrome in the United States, 2004–16. Health Aff. 2020;39(5):764–767. - PMC - PubMed
    1. Wilson N, Kariisa M, Seth P, Smith H, Davis NL. Drug and opioid-involved overdose deaths – United States, 2017–2018. MMWR Morb Mortal Wkly Rep. 2020;69(11):290–297. - PMC - PubMed
    1. Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization – United States, 1999–2014. MMWR Morb Mortal Wkly Rep. 2018;67(31):845–849. - PMC - PubMed
    1. Winkelman TNA, Villapiano N, Kozhimannil KB, Davis MM, Patrick SW. Incidence and costs of neonatal abstinence syndrome among infants with Medicaid. Pediatrics. 2018;141(4): e20173520–2014. - PMC - PubMed

Substances